These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 18478336
1. Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States. Atkinson C, Newton KM, Stanczyk FZ, Westerlind KC, Li L, Lampe JW. Cancer Causes Control; 2008 Dec; 19(10):1085-93. PubMed ID: 18478336 [Abstract] [Full Text] [Related]
2. Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes. Frankenfeld CL, McTiernan A, Tworoger SS, Atkinson C, Thomas WK, Stanczyk FZ, Marcovina SM, Weigle DS, Weiss NS, Holt VL, Schwartz SM, Lampe JW. J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):399-408. PubMed ID: 15145450 [Abstract] [Full Text] [Related]
3. Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States. Atkinson C, Newton KM, Bowles EJ, Yong M, Lampe JW. Am J Clin Nutr; 2008 Mar; 87(3):679-87. PubMed ID: 18326607 [Abstract] [Full Text] [Related]
4. Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States. Atkinson C, Newton KM, Aiello Bowles EJ, Lehman CD, Stanczyk FZ, Westerlind KC, Li L, Lampe JW. Breast Cancer Res Treat; 2009 Aug; 116(3):587-94. PubMed ID: 18821061 [Abstract] [Full Text] [Related]
5. Daidzein-metabolizing phenotypes in relation to bone density and body composition among premenopausal women in the United States. Atkinson C, Newton KM, Yong M, Stanczyk FZ, Westerlind KC, Li L, Lampe JW. Metabolism; 2012 Dec; 61(12):1678-82. PubMed ID: 22819530 [Abstract] [Full Text] [Related]
6. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein. Frankenfeld CL, Atkinson C, Wähälä K, Lampe JW. Eur J Clin Nutr; 2014 Apr; 68(4):526-30. PubMed ID: 24569543 [Abstract] [Full Text] [Related]
7. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women. Frankenfeld CL, McTiernan A, Aiello EJ, Thomas WK, LaCroix K, Schramm J, Schwartz SM, Holt VL, Lampe JW. Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1156-62. PubMed ID: 15247126 [Abstract] [Full Text] [Related]
11. Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes. Frankenfeld CL, McTiernan A, Thomas WK, LaCroix K, McVarish L, Holt VL, Schwartz SM, Lampe JW. Maturitas; 2006 Feb 20; 53(3):315-24. PubMed ID: 16019168 [Abstract] [Full Text] [Related]